Hyperphosphatemic Familial Tumoral Calcinosis: Genetic Models of Deficient FGF23 Action
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hyperphosphatemic Familial Tumoral Calcinosis: Genetic Models of Deficient FGF23 Action
Authors
Keywords
Fibroblast growth factor 23, FGF23, Hyperphosphatemia, Hyperphosphatemic familial tumoral calcinosis, Tumoral calcinosis
Journal
Current Osteoporosis Reports
Volume 13, Issue 2, Pages 78-87
Publisher
Springer Nature
Online
2015-02-05
DOI
10.1007/s11914-015-0254-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medical Treatment for Tumoral Calcinosis with Eight Years of Follow-up: A Report of Four Cases
- (2016) Ali Zein et al. Journal of Orthopaedic Surgery
- The Case | Ectopic calcifications in a child
- (2015) Vaibhav S. Keskar et al. KIDNEY INTERNATIONAL
- Hyperphosphatemic familial tumoral calcinosis: Response to acetazolamide and postulated mechanisms
- (2014) Gal Finer et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease
- (2012) Hirofumi Masai et al. ATHEROSCLEROSIS
- Circulating αKlotho influences phosphate handling by controlling FGF23 production
- (2012) Rosamund C. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Intestinal Phosphate Transport
- (2011) Yves Sabbagh et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- The Regulation of Renal Phosphate Transport
- (2011) Judith Blaine et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho)
- (2011) Emily G. Farrow et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis
- (2011) Alan Yancovitch et al. JOURNAL OF BONE AND MINERAL METABOLISM
- APhexmutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells
- (2011) Shoji Ichikawa et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Calcitonin Administration in X-Linked Hypophosphatemia
- (2011) Eva S. Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical variability of familial tumoral calcinosis caused by novelGALNT3mutations
- (2010) Shoji Ichikawa et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype
- (2010) Hua Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Tumoral calcinosis
- (2010) Mirian C. H. Janssen et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Ablation of theGalnt3Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite IncreasedFgf23Expression
- (2009) Shoji Ichikawa et al. ENDOCRINOLOGY
- Familial Tumoral Calcinosis Caused by a Novel FGF23 Mutation: Response to Induction of Tubular Renal Acidosis with Acetazolamide and the Non-Calcium Phosphate Binder Sevelamer
- (2009) Juan Javier Lammoglia et al. HORMONE RESEARCH
- Familial Tumoral Calcinosis: A Forty-Year Follow-up on One Family
- (2009) Kelly D Carmichael et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Physiological Regulation and Disorders of Phosphate Metabolism -Pivotal Role of Fibroblast Growth Factor 23-
- (2008) Seiji Fukumoto INTERNAL MEDICINE
- A case of familial tumoral calcinosis/hyperostosis–hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features
- (2008) C. E. Dumitrescu et al. OSTEOPOROSIS INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now